Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • Log out
  • Log in
  • Subscribe
  • My alerts

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • Subscribe
  • My alerts
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
  • ALERTS
  • FOR AUTHORS
    • Preparing a Manuscript
    • Submission Guidelines
    • Fees
    • Journal Club
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Articles, Cellular/Molecular

Actin Tyrosine-53-Phosphorylation in Neuronal Maturation and Synaptic Plasticity

Enni Bertling, Jonas Englund, Rimante Minkeviciene, Mikko Koskinen, Mikael Segerstråle, Eero Castrén, Tomi Taira and Pirta Hotulainen
Journal of Neuroscience 11 May 2016, 36 (19) 5299-5313; DOI: https://doi.org/10.1523/JNEUROSCI.2649-15.2016
Enni Bertling
1Neuroscience Center and
4Minerva Institute for Medical Research, 00290 Helsinki, Finland, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Englund
1Neuroscience Center and
2Department of Biosciences, Physiology and Neuroscience, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rimante Minkeviciene
1Neuroscience Center and
4Minerva Institute for Medical Research, 00290 Helsinki, Finland, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rimante Minkeviciene
Mikko Koskinen
1Neuroscience Center and
5Department of Neuroscience, Karolinska Institutet, SE-171 77 Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikael Segerstråle
2Department of Biosciences, Physiology and Neuroscience, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eero Castrén
1Neuroscience Center and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eero Castrén
Tomi Taira
3Department of Veterinary Biosciences, University of Helsinki, 00014 Helsinki, Finland,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pirta Hotulainen
1Neuroscience Center and
4Minerva Institute for Medical Research, 00290 Helsinki, Finland, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pirta Hotulainen
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Amount of actin Y53 phosphorylation changes during neuronal maturation and upon glycine application in cortical neurons. A, Western blot using pY53-actin-specific antibody shows that actin is phosphorylated in hippocampal neurons and the level of phosphorylation increases with Na3VO4 treatment. The total amount of actin was controlled using AC-15 actin antibody. VAN, 15 min 1 mm Na3VO4 treatment. B, Quantification of blots in A shown as the ratio of pY53-actin/total actin normalized to control. Graph represents four independent experiments. The amount of recognized phosphorylated actin was increased 3.0-fold by phosphatase inhibition. *p < 0.05, nonparametric Kruskal–Wallis test. C, Similar experiment as in A, but pY53-actin was detected using commercial pY53-actin antibody (ECM, ECM Biosciences) and cortical neuron cultures were used. D, Quantification of blots in C shown as the ratio of pY53-actin/total actin normalized to control. Graph represents five independent experiments. The amount of recognized phosphorylated actin was increased 2.0-fold by phosphatase inhibition. **p < 0.01, nonparametric Kruskal–Wallis test. E, F, Actin and pY53-actin migrated at similar speeds in normal SDS-PAGE gels (E), but phosphorylated actin migrated more slowly in Phos-tag gel (F). Commercial pY53-actin antibody (ECM Biosciences) detected three different bands in Phos-tag gel but no bands the size of nonphosphorylated actin. Data represent three independent experiments. G, Cortical neurons were cultured for 7, 14, and 21 DIV and lysates were run on SDS-PAGE and blotted against pY53-actin (ECM Biosciences) or total actin (AC-15). H, Quantification of G revealing that Y53 phosphorylation decreases by DIV21 (relative phosphorylation amounts: DIV7 = 1.0, DIV14 = 1.0, DIV21 = 0.2). Graph represents three analyzed blots (two different antibodies) from two independent experiments. *p < 0.05, nonparametric Kruskal–Wallis test. I, Freshly diluted 200 μm glycine in HBS was applied to DIV14 cortical cultures for 3 min after a 10 min incubation with blockers TTX, strychnine, and picrotoxin. Cells were then washed using HBS and lysed after a 10- or 30 min incubation in HBS. Samples were blotted against pAkt, Akt, pY53-actin (ECM), and total actin. J, pAkt levels were increased 1.9-fold 10 and 30 min after glycine application. K, The amount of pY53-actin was increased 2.1-fold 10 min after glycine application, but the increase in phosphorylation diminished after 30 min (1.4-fold increase compared with preinduction). Graph represents four independent experiments. *p < 0.05, nonparametric Kruskal–Wallis test. Data are represented as mean ± SEM.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Actin Y53 phosphorylation is a strictly localized phenomenon. A, Immunofluorescence staining of primary DIV10 hippocampal low-density culture using anti-pY53-actin specific antibody. Y53-phosphorylated actin is located throughout dendrites and filopodial protrusions in a punctate manner. Scale bar, 15 μm. B, Immunofluorescence staining of primary DIV14 hippocampal neurons using pY53-actin specific antibody shows the localization of pY53-actin to dendritic spine heads. Cells are transfected with GFP-actin to highlight a single dendrite. Images from one confocal layer (z = 0.450 μm) are shown. Arrows indicate staining in spine heads. Scale bars, 5 μm. C, Immunofluorescence staining of mCherry-actin-transfected primary DIV14 hippocampal neurons using pY53-actin antibody (ECM Biosciences). Images from one confocal layer (z = 0.450 μm) are shown. Antibody staining shows clear localization in spine heads (arrows). Scale bars, 5 μm. Data in A–C represent five independent experiments.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Low levels of Y53E-actin expression enhance the development of lamellipodia and hinder the establishment of stress fibers. A, Actin structures visualizing Y53 and adjacent amino acids. Generated mutations (Y53E and Y53A) visualized by modeled structures. Y53 phosphorylation results in the formation of hydrogen bonds with amino acids Gly48, Gln49, and Lys61, stabilizing the D-loop. Y53E mutation generates a negative charge mimicking the phosphorylated form of actin. Putative hydrogen bonds are indicated in the image. In the nonphosphorylated form and the Y53A mutation, the D-loop is flexible and thus not seen in the structure. Images were generated using the program PyMOL (http://pymol.sourceforge.net/) starting from the structures PDB 3CI5 (pY53-actin) and PDB 3CI5 (nonphosphorylated actin; Baek et al., 2008). B, Images taken of U2OS cells with high and low laser powers reveal different levels in GFP-actin expression and how GFP-actin expression levels affect phalloidin staining intensity. Scale bar, 10 μm. C, When the GFP intensity in the high-expressing cell shown in B is set to 100%, ImageJ intensity analysis reveals that the low-expressing cells used in these experiments express only 6% of this maximum expression level. The intensity of phalloidin staining in these low-expressing cells is the same as in nontransfected controls. D, F-actin staining (phalloidin-594) of U2OS cells expressing GFP-(wt/Y53E/ Y53A)-actin. Scale bars, 10 μm. E, GFP-actin constructs are distributed differently between lamellipodial actin and stress fibers: wt ratio = 1.0 (similar intensity in lamellipodium and in stress fibers); Y53E ratio = 1.8; Y53A ratio = 1.0. Data in E and F represent n(wt) = 17, n(Y53E) = 14, n(Y53A) = 11 cells pooled from two independent experiments. **p < 0.01 one-way ANOVA with Bonferroni's post hoc test. F, Overexpression of GFP-Y53E-actin causes a shift toward lamellipodial actin: wt ratio = 1.0 (similar intensity in lamellipodium and in stress fibers), Y53E ratio = 1.4, Y53A ratio = 1.0. *p < 0.05 one-way ANOVA with Bonferroni's post hoc test. Data are represented as mean ± SEM.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Expression of mutant actin mimicking pY53-actin increases the proportion of mushroom-shaped dendritic spines. A, GFP-actin-, GFP-Y53E-actin-, and GFP-Y53A-actin-expressing primary hippocampal neurons at DIV14. Scale bars, 5 μm. B, C, Quantification of spine morphology from neurons cotransfected with mCherry-actins and free GFP revealed an increased proportion of mushroom spines in mCherry-Y53E-actin expressing neurons. Proportions of thin, mushroom, and stubby spine morphologies: wt: 20% thin, 54% mushroom, 27% stubby, total density = 0.80 spines/μm; Y53E: 15% thin, 61% mushroom, 24% stubby, total density = 0.83 spines/μm; Y53A: 24% thin, 51% mushroom, 25% stubby, total density = 0.66 spines/μm. Data in B–E represent n(wt) = 15 cells, 986 spines, 1342 μm of dendrite; n(Y53E) = 19 cells, 1522 spines, 1998 μm of dendrite; n(Y53A) = 15 cells, 1119 spines, 1587 μm of dendrite pooled from four independent experiments.*p < 0.05 one-way ANOVA with Bonferroni's post hoc test. D, Size distribution of spines analyzed in B and C. Spines are grouped with 0.2 μm intervals. Spines with small heads (<0.2 μm) were significantly reduced in Y53E-actin-expressing neurons. E, GFP-Y53A-actin induces branching of spine heads. Branched spine densities: wt = 0.03, Y53E = 0.04; Y53A = 0.10 spines/μm. ***p < 0.001 one-way ANOVA with Bonferroni's post hoc test. F, Free GFP and mCherry-actin expressed in a primary hippocampal neuron. Expression plot profile was generated from the line shown in the picture. Distribution of actin between spine and dendrite was measured and normalized to GFP signal. Scale bars, 1 μm. G, mCherry-Y53A-actin showed a reduced concentration in spine heads compared with wt- and mCherry-Y53E-actin. Head versus dendrite localizations: wt = 2.3, Y53E = 2.3, Y53A = 1.7. Data represent n = 10 cells, 100 spines for each actin construct pooled from two independent experiments. ***p < 0.001 one-way ANOVA with Bonferroni's post hoc test. H, PSD densities and sizes of PSDs of GFP-(wt/Y53E/Y53A)-actin expressing cells were analyzed based on PSD labeling by SAP97-mCherry. Scale bars, 1 μm. I, Quantification shows that PSD density was significantly increased in cells expressing GFP-Y53E-actin. Density of PSDs: wt = 0.34 PSD/μm, n = 17 cells, 1707 μm of dendrite; Y53E = 0.40 PSD/μm, n = 14 cells, 1394 μm of dendrite; Y53A = 0.33 PSD/μm, n = 14 cells, 1227 μm of dendrite. Data are pooled from two independent experiments. *p < 0.05 one-way ANOVA with Bonferroni's post hoc test. J, Quantification of PSD widths shows that PSD sizes were significantly increased in cells expressing GFP-Y53E-actin together with SAP97-mCherry, whereas, in cells expressing GFP-Y53A-actin, PSD accumulations were significantly smaller. PSD width: wt = 0.9 μm, n = 10 cells, 270 spines with PSD; Y53E = 1.1 μm, n = 10 cells, 235 spines with PSD; Y53A = 0.7 μm, n = 10 cells, 341 spines with PSD. Data are pooled from two independent experiments. *p < 0.05, ***p < 0.001, one-way ANOVA with Bonferroni's post hoc test. K, Presynaptic site densities and widths of synapsin staining next to GFP-(wt/Y53E/Y53A)-actin expressing spines. Scale bars, 1 μm. L, Quantification shows that presynaptic site density was significantly increased in cells expressing GFP-Y53E-actin. Densities: wt = 0.28 presynaptic contacts/μm, n = 14 cells, 1070 μm of dendrite; Y53E = 0.39, n = 12 cells, 835 μm of dendrite; Y53A = 0.27, n = 13 cells, 1031 μm of dendrite. Data are pooled from three independent experiments. *p < 0.05 one-way ANOVA with Bonferroni's post hoc test. M, Quantification of the width of presynaptic contacts shows that widths were significantly increased in cells expressing GFP-Y53E-actin, whereas, in cells expressing GFP-Y53A-actin, synapsin accumulations were significantly reduced. wt = 0.58 μm, n = 6 cells, 241 pre synaptic sites; Y53E = 0.77 μm, n = 4 cells, 269 presynaptic sites; Y53A = 0.50 μm, n = 8 cells, 252 presynaptic sites. Data are pooled from two independent experiments. **p < 0.01, ***p < 0.001, one-way ANOVA with Bonferroni's post hoc test. Data are represented as mean ± SEM.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Expression of mutant actin mimicking pY53-actin increases the turnover rate of actin filaments and spine head dynamics. A, Example images presenting fluorescence recovery of GFP-(wt/Y53E/Y53A)-actin in dendritic spines of primary DIV14 hippocampal neurons. B, Analyses of FRAP assays show the mean GFP-actin fluorescence recovery curves of GFP-(wt/Y53E/Y53A)-actin. C, Stable pool sizes measured from the mean FRAP curves of individual cells show that GFP-Y53E-actin has a smaller, whereas GFP-Y53A-actin has a larger, stable-F-actin pool fraction. Stable pool size: wt = 11%, Y53E = 6%, Y53A = 20%. *p < 0.05, ***p < 0.001, one-way ANOVA with Bonferroni's post hoc test. D, GFP-Y53E-actin recovery half-time is significantly shorter, whereas GFP-Y53A-actin shows no significant change compared with GFP-wt-actin. Recovery half-time of dynamic pool: wt: 8.8 s; Y53E: 5.5 s; Y53A: 7.7 s. Data in C and D represent n(wt) = 14 cells, 51 spines, n(Y53E) = 14 cells, 50 spines, n(Y53A) = 14 cells, 55 spines pooled from three independent experiments. ***p < 0.001, one-way ANOVA with Bonferroni's post hoc test. E, Analyses of FRAP assays show the mean GFP-actin fluorescence recovery curves in dendritic spines of primary DIV14 hippocampal neurons coexpressing mCherry-tagged wt-, Y53E-, or Y53A-actin. F, Stable pool sizes measured from the mean FRAP curves of individual cells show that GFP-actin in spines coexpressing mCherry-Y53E-actin have a smaller stable-F-actin pool fraction, whereas spines coexpressing mCherry-Y53A-actin have a larger stable-F-actin pool fraction. Stable pool size: wt = 13%, Y53E = 7%, Y53A = 20%. **p < 0.01 one-way ANOVA with Bonferroni's post hoc test. G, GFP-actin recovery half-time of dynamic F-actin pool is not significantly different in cells expressing mCherry-(wt/Y53E/Y53A)-actin together with GFP-actin. Recovery half-time of dynamic pool: wt: 9.7 s; Y53E: 9.0 s; Y53A: 8.2 s. Data in F and G represent n(wt) = 15 cells, 58 spines, n(Y53E) = 14 cells, 56 spines, n(Y53A) = 15 cells, 59 spines pooled from four independent experiments. H, Representative images used in spine length and width analyses. Images of GFP fluorescence taken at 2 min intervals. Scale bars, 1 μm. I, Analysis of spine motility by measuring the mean head width and spine length fluctuation at 2 min intervals. Symbols indicating the time points refer to the spines marked with corresponding symbols in H. J, Fluctuation percentages were averaged to give a motility index for cells expressing mCherry-(wt/Y53E/Y53A)-actin together with GFP. The magnitude of spine head movement was larger in cells expressing Y53E-actin compared with wt-actin (wt: 17%, n = 6 cells, 340 spines; Y53E: 20%, n = 5 cells, 375 spines; Y53A: 17%, n = 6 cells, 420 spines). No significant change in spine length fluctuation was observed (wt: 16%, Y53E: 15%, Y53A: 16%). Data are pooled from three independent experiments. **p < 0.01 one-way ANOVA with Bonferroni's post hoc test. Data are represented as mean ± SEM.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Expression of Y53E-actin in rat hippocampus decreases dendritic spine density and attenuates LTP formation. A, Lentiviral transduction was performed at P1–P4 in rat hippocampi. Higher-magnification confocal images of the CA1 area show transduction efficiency used for imaging and for LTP recordings. DAPI nuclear staining is shown in red, GFP-actin fluorescence in green. Transduction efficiency in slices used for LTP recording is ∼35%. Scale bars, 10 μm. B, Dendrites of CA1 pyramidal hippocampal neurons at P15–P19 expressing GFP-tagged wt-, Y53E-, or Y53A-actin. Similar to wt, GFP-Y53E-actin localizes to spines, whereas GFP-Y53A-actin shows shaft localization. Scale bars, 5 μm. C, Quantification of spine morphology reveals that the total spine number is diminished in neurons expressing GFP-Y53E-actin. Expression of GFP-Y53A-actin shifts spine type distribution to thin spines without altering the total spine density: wt: thin = 0.31, mushroom = 0.77, stubby = 0.40, total = 1.51 spines/μm; n = 11 cells, 1235 spines, 821 μm dendrite, pooled from 3 rats; Y53E: thin = 0.31, mushroom = 0.51, stubby = 0.28, total = 1.00 spines/μm; n = 10 cells, 795 spines, 746 μm dendrite, pooled from 3 rats; Y53A: thin = 0.68, mushroom = 0.40, stubby = 0.41, total = 1.50 spines/μm; n = 10 cells, 964 spines, 637 μm dendrite, pooled from 3 rats. **p < 0.01, ***p < 0.001, one-way ANOVA with Bonferroni's post hoc test. D, I/O ratios did not differ between slices expressing different actin constructs. The number of recordings from slices expressing wt-, Y53E-, and Y53A-actin constructs were 13 (13 rats), 13 (10 rats), and 17 (12 rats), respectively. E, No significant differences in the PPF were found between the wt-, Y53E-, and Y53A-actin construct groups [n(wt) = 12 (12 rats), n(Y53E) = 14 (13 rats), and n(Y53A) = 14 (12 rats)]. F, G, Pooled data from recordings of fEPSPs in the CA1 of hippocampal slices expressing wt-actin (F, G), Y53E-actin (F),and Y53A-GFP-actin (G). A stimulation interval of 20 s was used and every third response is shown in the graph. TFS was applied at 0 min. At 35–40 min, the fEPSP was potentiated 37 ± 4% [n = 18 slices (13 rats)] in wt-actin-expressing slices, 22 ± 4% [n = 11 (8 rats)] in Y53E-actin-expressing slices, and 30 ± 2% [n = 21 (12 rats)] in Y53A-actin-expressing slices. *p < 0.05, Kruskal–Wallis test with Dunn–Bonferroni post hoc method. H, Superimposed average fEPSP responses at −5 min (1) and 35 min (2) for all groups. Data are represented as mean ± SEM.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Phosphorylation level of endogenous actin increases during LTP formation in acute hippocampal slices. A, LTP was induced in rat hippocampal slices similar to the experiment presented in Figure 6 (circles). The CA1s of the slices were frozen in liquid nitrogen 35 min after LTP induction. In addition to slices with LTP induction, we collected Western blot samples from control slices recorded without LTP induction (triangles). At 32 min, the fEPSP was potentiated 55 ± 2% [n = 8 slices (8 rats)] in LTP-induced slices and 4 ± 2% [n = 5 (5 rats)] in slices without LTP induction, p = 0.003. **p < 0.01, nonparametric Kruskal–Wallis test. B, The success of LTP induction was further controlled by measuring the known LTP-responsive Akt Ser473 phosphorylation (Racaniello et al., 2010) and pY53-actin levels were detected with pY53-actin antibodies (ECM Biosciences). C, pAkt levels were increased 2.7-fold 35 min after LTP induction. D, Western blotting against pY53-actin revealed that actin phosphorylation was increased 2.3-fold in LTP-induced slices compared with control samples. Graph represents five independent experiments. *p < 0.05, nonparametric Wilcoxon signed-rank test. Data are represented as mean ± SEM.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Model figure illustrating the function of mutant actin constructs and the role of Y53 phosphorylation during dendritic spine maturation and LTP formation. A, Working model for the effects of the Y53E- and Y53A-actin expression on actin filament turnover. In a cellular context, there is a net addition of monomers at the plus end and net dissociation at the pointed end, leading to filament elongation occurring mainly at the plus end. The constant incorporation and dissociation of monomers at filament ends results in a “treadmilling” effect. Y53E-actin creates points with weaker actin–actin binding along the filament. When filaments break at these points, the filaments become shorter and the increase in numbers of both plus and minus ends enhances the turnover rate. Y53A-actin creates higher affinity binding with adjacent actin monomers, thus slowing down the depolymerization rate at minus ends. This “pointed end capping” increases filament length. B, During spine morphogenesis, actin filaments are maintained highly dynamic by Y53 phosphorylation (spine on left). High-frequency synapse activation induces reorganization, polymerization, and stabilization of actin filaments. We propose that actin phosphorylation serves as a mechanism to break actin filaments into shorter filaments to facilitate the reorganization of the actin cytoskeleton (spine in the middle). In turn, dephosphorylation is required for the stabilization of actin filaments during LTP maintenance or during dendritic spine maturation (spine on right).

Back to top

In this issue

The Journal of Neuroscience: 36 (19)
Journal of Neuroscience
Vol. 36, Issue 19
11 May 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Actin Tyrosine-53-Phosphorylation in Neuronal Maturation and Synaptic Plasticity
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Actin Tyrosine-53-Phosphorylation in Neuronal Maturation and Synaptic Plasticity
Enni Bertling, Jonas Englund, Rimante Minkeviciene, Mikko Koskinen, Mikael Segerstråle, Eero Castrén, Tomi Taira, Pirta Hotulainen
Journal of Neuroscience 11 May 2016, 36 (19) 5299-5313; DOI: 10.1523/JNEUROSCI.2649-15.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Actin Tyrosine-53-Phosphorylation in Neuronal Maturation and Synaptic Plasticity
Enni Bertling, Jonas Englund, Rimante Minkeviciene, Mikko Koskinen, Mikael Segerstråle, Eero Castrén, Tomi Taira, Pirta Hotulainen
Journal of Neuroscience 11 May 2016, 36 (19) 5299-5313; DOI: 10.1523/JNEUROSCI.2649-15.2016
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • actin cytoskeleton
  • dendritic spines
  • LTP
  • phosphorylation
  • spinogenesis
  • synaptic plasticity

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Choice Behavior Guided by Learned, But Not Innate, Taste Aversion Recruits the Orbitofrontal Cortex
  • Maturation of Spontaneous Firing Properties after Hearing Onset in Rat Auditory Nerve Fibers: Spontaneous Rates, Refractoriness, and Interfiber Correlations
  • Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration
Show more Articles

Cellular/Molecular

  • The Cellular Electrophysiological Properties Underlying Multiplexed Coding in Purkinje Cells
  • Phase-locking requires efficient Ca2+ extrusion at the auditory hair cell ribbon synapses
  • Dopamine Transporter Localization in Medial Forebrain Bundle Axons Indicates Its Long-Range Transport Primarily by Membrane Diffusion with a Limited Contribution of Vesicular Traffic on Retromer-Positive Compartments
Show more Cellular/Molecular
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(JNeurosci logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.